{
  "meta": {
    "title": "Pharmacology_St_2",
    "url": "https://brainandscalpel.vercel.app/pharmacology-st-2-5c145932.html",
    "scrapedAt": "2025-11-30T12:47:45.698Z"
  },
  "questions": [
    {
      "text": "What is the half-life of digoxin?",
      "choices": [
        {
          "id": 1,
          "text": "24 hrs"
        },
        {
          "id": 2,
          "text": "40 hrs"
        },
        {
          "id": 3,
          "text": "72 hrs"
        },
        {
          "id": 4,
          "text": "60 hrs"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The plasma <strong>half-life of digoxin</strong> is around <strong>40 hours</strong> (36-40 hours).</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Digitoxin&nbsp;</td>\n<td>Digoxin&nbsp;</td>\n</tr>\n<tr>\n<td>Oral absorption&nbsp;</td>\n<td>Very good (90-100%)&nbsp;</td>\n<td>Good (60-80%)&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>Plasma protein binding&nbsp;&nbsp;</td>\n<td>95%(t<sub>1/2</sub>&nbsp;5-7 days)&nbsp;</td>\n<td>25%(t<sub>1/2</sub>&nbsp;40 hrs)&nbsp;</td>\n</tr>\n<tr>\n<td>Elimination&nbsp;</td>\n<td>Hepatic metabolism&nbsp;</td>\n<td>Renal excretion (by glomerular filtration)&nbsp;</td>\n</tr>\n<tr>\n<td>Dose adjustment in&nbsp;</td>\n<td>Liver failure&nbsp;</td>\n<td>Kidney failure&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\">Therapeutic levels of digoxin in the range of 0.5-0.8 ng/ml are beneficial.&nbsp;An increase in levels &gt;1.2 ng/mL is associated with increased mortality.</p>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4740",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is an aromatase inhibitor?",
      "choices": [
        {
          "id": 1,
          "text": "Tamoxifen"
        },
        {
          "id": 2,
          "text": "Danazol"
        },
        {
          "id": 3,
          "text": "Ospemifene"
        },
        {
          "id": 4,
          "text": "Exemestane"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Exemestane</strong> is an aromatase inhibitor.</p>\n<p>Estrogen is locally produced from androgen by the action of the aromatase enzyme.&nbsp;Locally synthesized estrogens play an important role in the development of breast cancer because they are estrogen-dependent for proliferation.</p>\n<p><strong>Aromatase inhibitors</strong> decrease estrogen synthesis and are widely used now in the treatment of <strong>breast cancer</strong> in postmenopausal women.</p>\n<p>Aromatase inhibitors are:</p>\n<ul>\n<li>Letrozole</li>\n<li>Anastrozole</li>\n<li>Exemestane (Irreversible inhibitor)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0773",
      "difficulty": "medium"
    },
    {
      "text": "A 25-year-old patient presented to the ER with an acute attack of migraine. You decide to administer a long-acting triptan. Which among the following do you choose?",
      "choices": [
        {
          "id": 1,
          "text": "Sumatriptan"
        },
        {
          "id": 2,
          "text": "Rizatriptan"
        },
        {
          "id": 3,
          "text": "Frovatriptan"
        },
        {
          "id": 4,
          "text": "Zolmitriptan"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Frovatriptan</strong> is a <strong>long-acting</strong> triptan among&nbsp;other triptans.</p>\n<p><strong>Headache recurrences</strong> in an attack are <strong>less</strong> with longer-acting triptans like frovatriptan and naratriptan but onset of action may be slow.</p><hr><h3>Related Pearl: Triptans - 5HT 1B/1D agonists</h3><p>Few important properties of triptans:</p>\n<ul>\n<li><strong>Longest </strong>acting triptan: <strong>Frovatriptan</strong></li>\n<li><strong>Fastest</strong> (Oral) acting triptan: <strong>Rizatriptan</strong></li>\n<li><strong>Least bioavailability</strong> (Oral): <strong>Sumatriptan</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7449",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drug does not act by inhibiting a transporter?",
      "choices": [
        {
          "id": 1,
          "text": "Tiagabine"
        },
        {
          "id": 2,
          "text": "Probenecid"
        },
        {
          "id": 3,
          "text": "Acetazolamide"
        },
        {
          "id": 4,
          "text": "Reserpine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Acetazolamide is a <strong>noncompetitive inhibitor of carbonic anhydrase enzyme</strong> and does not inhibit transporter.</p>\n<ul>\n<li>Tiagabine: inhibits GABA transporter GAT1 (option a)</li>\n<li>Probenecid: inhibits organic anion transporter (option b)</li>\n<li>Reserpine: inhibits vesicular monoamine transporter (option d)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4504",
      "difficulty": "medium"
    },
    {
      "text": "The shortest acting calcium channel blocker is _______.",
      "choices": [
        {
          "id": 1,
          "text": "Nifedipine"
        },
        {
          "id": 2,
          "text": "Clevidipine"
        },
        {
          "id": 3,
          "text": "Amlodipine"
        },
        {
          "id": 4,
          "text": "Felodipine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<ul>\n<li>Clevidipine is a novel dihydropyridine available only for intravenous administration.</li>\n<li>It has a very rapid onset of action (2&ndash;4 min) and <strong>a very short half-life (1&ndash;2 min).</strong></li>\n<li>It&nbsp;is metabolized by esterases in blood.</li>\n<li>It is primarily indicated in the acute management of hypertension. &nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1447",
      "difficulty": "medium"
    },
    {
      "text": "A 23-year-old lady presented to the gynecology OPD with complaints of amenorrhea and milky discharge from her breasts. Her urine pregnancy test is negative and her serum prolactin level is 175 µg/L. The resident prescribes a long-acting D2 agonist. Which of the following drugs is she likely to have been prescribed?",
      "choices": [
        {
          "id": 1,
          "text": "Bromocriptine"
        },
        {
          "id": 2,
          "text": "Lisuride"
        },
        {
          "id": 3,
          "text": "Cabergoline"
        },
        {
          "id": 4,
          "text": "Apomorphine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario depicts <strong>hyperprolactinemia</strong>. Cabergoline is a&nbsp;<strong>long-acting D2 agonist. </strong></p>\n<p>Its<strong>&nbsp;</strong>t1/2 is &gt;60 hours. It is indicated for the treatment of <strong>hyperprolactinemia</strong> and acromegaly.</p>\n<p>Bromocriptine, lisuride, and apomorphine are <strong>short-acting</strong> when compared with cabergoline.</p>\n<p><strong>Bromocriptine</strong> is an ergot alkaloid derivative used in the management of type 2 diabetes mellitus, hyperprolactinemia, acromegaly, and Parkinson's disease.&nbsp;Cabergoline is preferred over bromocriptine for hyperprolactinemia due to lower adverse effects such as nausea and also due to dosing advantage (twice a week instead of daily dosing).</p>\n<p><strong>Lisuride</strong> is indicated in <strong>early Parkinson's disease</strong> but is also known to decrease prolactin levels and prevent migraine attacks.&nbsp;<strong>Apomorphine</strong>&nbsp;is a morphine derivative used to treat hypomobile <strong>\"off\" episodes</strong> of advanced Parkinson's disease.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9167",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drugs has increased absorption with food?",
      "choices": [
        {
          "id": 1,
          "text": "Captopril"
        },
        {
          "id": 2,
          "text": "Digoxin"
        },
        {
          "id": 3,
          "text": "Levodopa"
        },
        {
          "id": 4,
          "text": "Griseofulvin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<ul>\n<li>Oral absorption of griseofulvin is erratic because of low water solubility. <strong>Absorption is increased by administering with fatty food and by micro fining the drug particles.</strong> Ultramicrofine preparations with better absorption profile are now available.</li>\n<li>Drugs in which the absorption is enhanced by food (mainly fatty food)\n<ul>\n<li>Lumefantrine</li>\n<li>Griseofulvin</li>\n<li>Carbamazepine</li>\n<li>Chloroquine</li>\n<li>Riboflavin</li>\n<li>Spironolactone</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4456",
      "difficulty": "easy"
    },
    {
      "text": "Bone resorption is enhanced by____",
      "choices": [
        {
          "id": 1,
          "text": "PGD2"
        },
        {
          "id": 2,
          "text": "PGE2"
        },
        {
          "id": 3,
          "text": "PGF2"
        },
        {
          "id": 4,
          "text": "PGI2"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<ul>\n<li><strong>PGE2 acts via EP4 receptors to increase bone turnover that is both stimulations of bone resorption and formation. </strong></li>\n<li>Prostaglandins especially PGE2 may be involved in fracture healing. EP4 deletion or NSAID use in experimental animals is associated with impaired fracture healing.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0005",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drugs is associated with coronary steal phenomenon?",
      "choices": [
        {
          "id": 1,
          "text": "Dipyridamole"
        },
        {
          "id": 2,
          "text": "Diltiazem"
        },
        {
          "id": 3,
          "text": "Propranolol"
        },
        {
          "id": 4,
          "text": "Verapamil"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Coronary steal phenomenon is seen with <strong>dipyridamole</strong>.</p>\n<p>In patients with <strong>partial obstruction of coronary vasculature</strong>, a region of ischemia develops in the myocardium. In the absence of drugs, <strong>arterioles in the ischemic areas</strong> are usually <strong>maximally dilated</strong> as a result of local compensatory mechanisms.&nbsp;</p>\n<p>When <strong>dipyridamole</strong> is administered, it acts as a <strong>nonselective arteriolar dilator</strong>. It can only dilate the vessels of the normal myocardium as the vessels of the ischemic myocardium are already maximally dilated. This <strong>diverts</strong> (steals) the<strong> blood away from</strong> the <strong>ischemic myocardium</strong> towards the normal myocardium. This is termed as <strong>coronary steal phenomenon</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1457",
      "difficulty": "medium"
    },
    {
      "text": "What is the drug of choice for type IIa and IIb hyperlipoproteinemias?",
      "choices": [
        {
          "id": 1,
          "text": "Statins"
        },
        {
          "id": 2,
          "text": "Fibrates"
        },
        {
          "id": 3,
          "text": "Niacin"
        },
        {
          "id": 4,
          "text": "Bile acid sequestrants"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The drugs of choice for <strong>type IIa and IIb hyperlipoproteinemias</strong> are <strong>statins</strong>.&nbsp;</p>\n<p>In type IIa or IIb hyperlipoproteinemias, there is increased LDL cholesterol with +/- increase in TG.&nbsp; Statins have the <strong>maximum LDL lowering</strong> property among the hypolipidemic drugs. Therefore, they are the drugs of choice in this case.</p>\n<p>In <strong>type III/IV hyperlipoproteinemias,&nbsp;</strong>there is mainly an increase in triglyceride(TG) level<strong>. Fibrates</strong> reduce the TGs contained in VLDL and increase the HDL. So they are the drugs of choice for these conditions.</p><hr><h3>Related Pearl: Familial Dyslipidemias</h3><table>\n<tbody>\n<tr>\n<td>Type</td>\n<td>Increased levels&nbsp;</td>\n<td>Manifestation</td>\n</tr>\n<tr>\n<td>1. Hyperchylomicronemia(type I hyperlipoproteinemia)</td>\n<td>Chylomicrons, VLDL, TG&nbsp;</td>\n<td>Pancreatitis, hepatosplenomegaly, and xanthomas</td>\n</tr>\n<tr>\n<td>2.&nbsp;Familial hypercholesterolemia(type II&nbsp;hyperlipoproteinemia)</td>\n<td>LDL and cholesterol</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>3. Dysbetalipoproteinemia(type III hyperlipoproteinemia)</td>\n<td>Chylomicrons and VLDL</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>4. Hypertriglyceridemia(type IV hyperlipoproteinemia)</td>\n<td>VLDL and TG</td>\n<td>Pancreatitis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2034",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drugs does not produce oculogyric crisis?",
      "choices": [
        {
          "id": 1,
          "text": "Trifluperazine"
        },
        {
          "id": 2,
          "text": "Atropine"
        },
        {
          "id": 3,
          "text": "Prochlorperazine"
        },
        {
          "id": 4,
          "text": "Perphenazine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>oculogyric crisis</strong> is a <strong>severe manifestation of acute dystonia</strong> that is an acute side effect of drugs blocking D<sub>2</sub> receptors. Atropine is an antimuscarinic with no effect on D<sub>2 </sub>receptors.</p>\n<p>Options A, C, and D: Trifluoperazine, prochlorperazine, and perphenazine are <strong>typical antipsychotics with D2 antagonistic action</strong> that can <strong>cause</strong> the oculogyric <strong>crisis.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2362",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following receptors is a ligand-gated ion channel?",
      "choices": [
        {
          "id": 1,
          "text": "5-HT 1 receptor"
        },
        {
          "id": 2,
          "text": "5-HT 2 receptor"
        },
        {
          "id": 3,
          "text": "5-HT 3 receptor"
        },
        {
          "id": 4,
          "text": "5-HT 4-7 receptors"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The<strong> 5-HT<sub>3</sub> receptor</strong>&nbsp;is a&nbsp;<strong>ligand-gated ion channel receptor</strong>. It rapidly depolarizes nerve endings by opening the cation channels located within the receptor.</p>\n<p>The 5-HT<sub>3</sub> receptors are located in the GI tract (vagal &amp; splanchnic afferents) and the brain (nucleus tractus solitarius &amp; area postrema) and are involved in the emetic response. Hence&nbsp;5-HT3 receptor antagonists like&nbsp;ondansetron, dolasetron etc are used as antiemetics.</p>\n<p>All other 5-HT receptors are G-protein-coupled receptors.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7439",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following have cytoplasmic receptors?",
      "choices": [
        {
          "id": 1,
          "text": "Epinephrine"
        },
        {
          "id": 2,
          "text": "Insulin"
        },
        {
          "id": 3,
          "text": "FSH"
        },
        {
          "id": 4,
          "text": "Cortisol"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The receptors of cortisol are intracellular (cytoplasmic or nuclear) soluble proteins.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Mechanisms of Action of Hormones</h3><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Types of hormone receptors</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Hormones that bind to intracellular receptors</strong></td>\n</tr>\n<tr>\n<td rowspan=\"3\">Cytoplasmic receptors</td>\n<td>Glucocorticoids</td>\n</tr>\n<tr>\n<td>Mineralocorticoids</td>\n</tr>\n<tr>\n<td>Androgens</td>\n</tr>\n<tr>\n<td> </td>\n<td>Vitamin D</td>\n</tr>\n<tr>\n<td rowspan=\"2\">Nuclear receptors</td>\n<td>Thyroid hormones</td>\n</tr>\n<tr>\n<td>Vitamins A</td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Hormones that bind to cell surface receptors</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\">1. <strong>G-protein coupled receptors</strong> (GPCR)</td>\n</tr>\n<tr>\n<td rowspan=\"9\"><strong>Gs</strong>: stimulation of second messenger cAMP</td>\n<td>ACTH, CRH</td>\n</tr>\n<tr>\n<td>TSH, GHRH</td>\n</tr>\n<tr>\n<td>FSH, LH, hCG</td>\n</tr>\n<tr>\n<td>Vasopressin (V<sub>2</sub> receptors)</td>\n</tr>\n<tr>\n<td>Catecholamines (β receptors)</td>\n</tr>\n<tr>\n<td>Somatostatin</td>\n</tr>\n<tr>\n<td>Glucagon</td>\n</tr>\n<tr>\n<td>Secretin</td>\n</tr>\n<tr>\n<td>Parathyroid hormone</td>\n</tr>\n<tr>\n<td rowspan=\"3\"><strong>Gi: </strong>inhibition of second messenger cAMP</td>\n<td>Catecholamines (ɑ<sub>2</sub> receptors)</td>\n</tr>\n<tr>\n<td>Acetylcholine (M2, M4)</td>\n</tr>\n<tr>\n<td>Somatostatin</td>\n</tr>\n<tr>\n<td rowspan=\"11\">\n<p><strong>Gq</strong>: second messenger is phospholipase C or cGMP</p>\n</td>\n<td><strong>Phospholipase C (IP3 DAG pathway):</strong></td>\n</tr>\n<tr>\n<td>GnRH, GHRH, TRH</td>\n</tr>\n<tr>\n<td>Catecholamines (ɑ<sub>1</sub> receptors)</td>\n</tr>\n<tr>\n<td>Vasopressin (V<sub>1</sub> receptor)</td>\n</tr>\n<tr>\n<td>Gastrin</td>\n</tr>\n<tr>\n<td>Cholecystokinin</td>\n</tr>\n<tr>\n<td>Oxytocin</td>\n</tr>\n<tr>\n<td>Acetylcholine (M1, M3, M5)</td>\n</tr>\n<tr>\n<td><strong>cGMP:</strong></td>\n</tr>\n<tr>\n<td>Atrial natriuretic peptide</td>\n</tr>\n<tr>\n<td>Nitric oxide</td>\n</tr>\n<tr>\n<td colspan=\"2\">2. <strong>Tyrosine kinase</strong> receptors</td>\n</tr>\n<tr>\n<td rowspan=\"5\">Through the <strong>JAK-STAT</strong> (non-receptor tyrosine kinase) or <strong>MAP kinase</strong> (receptor tyrosine kinase) pathway </td>\n<td>Growth factors like IGF, VEGF, FGF, PDGF</td>\n</tr>\n<tr>\n<td>Growth hormone</td>\n</tr>\n<tr>\n<td>Erythropoietin</td>\n</tr>\n<tr>\n<td>Insulin</td>\n</tr>\n<tr>\n<td>Prolactin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br />Notes: <br />1. Even though the cytoplasmic receptors are present in the cytoplasm, once the <strong>hormone-receptor complex</strong> is formed it moves to the <strong>nucleus</strong> for its actions.</p>\n<p>2. <strong>Vitamin D</strong> is a <strong>cytoplasmic receptor.</strong> All intracellular receptors are inherently nuclear receptors as they bind and get activated at the nucleus as mentioned above but they have two sites of primary action- cytoplasm and nucleus. </p>\n<p>3. While receptor tyrosine kinases have intrinsic tyrosine kinase activity, non-receptor tyrosine kinases have an external tyrosine kinase component that interacts with the receptor as and when required. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4507",
      "difficulty": "medium"
    },
    {
      "text": "Bromocriptine’s primary mechanism of action in the treatment of type 2 diabetes is______",
      "choices": [
        {
          "id": 1,
          "text": "Increases insulin resistance"
        },
        {
          "id": 2,
          "text": "Increases glucose excretion"
        },
        {
          "id": 3,
          "text": "Decreases central sympathetic activity"
        },
        {
          "id": 4,
          "text": "Decreases glucose absorption"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<ul>\n<li>In type 2 diabetes, patients have low hypothalamic dopaminergic activity in morning. This results in higher sympathetic tone and increased blood glucose levels.</li>\n<li><strong>Bromocriptine acts as a sympatholytic dopamine agonist and improves glycemic control.</strong></li>\n</ul>\n<p>Note: </p>\n<ul>\n<li>Effects of sympatholytic action of bromocriptine \n<ul>\n<li>Decreased hepatic glucose production </li>\n<li><strong>Decrease in insulin resitance (option A)</strong></li>\n<li>Decrease in plasma FFA (Free fatty acids)/TG  </li>\n</ul>\n</li>\n<li>Remember: The formulation approved for type 2 diabetes is a quick release low dose formulation different from those, which are used for other indications. It is administered within 2 hours of awakening in type 2 diabetes patients.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9135",
      "difficulty": "medium"
    },
    {
      "text": "A patient who is on levodopa therapy presents with confusion, delusions of grandeur, and hallucinations. What is the most appropriate treatment for his condition?",
      "choices": [
        {
          "id": 1,
          "text": "Haloperidol"
        },
        {
          "id": 2,
          "text": "Chlorpromazine"
        },
        {
          "id": 3,
          "text": "Trifluperazine"
        },
        {
          "id": 4,
          "text": "Quetiapine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario is suggestive of<strong> levodopa-induced psychosis </strong>for which<strong> quetiapine </strong>is the most appropriate treatment.</p>\n<p><strong>Quetiapine</strong> and <strong>clozapine</strong> are the two atypical antipsychotics that are most effective and best tolerated in levodopa-induced psychosis<strong>.&nbsp;</strong></p>\n<p><strong>Typical antipsychotics&nbsp;</strong>are effective against levodopa-induced psychosis but may cause marked <strong>worsening of parkinsonism</strong>. Hence, atypical antipsychotics are deemed safer.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2883",
      "difficulty": "hard"
    },
    {
      "text": "In which of the following conditions is high dose methotrexate indicated in?",
      "choices": [
        {
          "id": 1,
          "text": "Osteosarcoma"
        },
        {
          "id": 2,
          "text": "Rhabdomyosarcoma"
        },
        {
          "id": 3,
          "text": "Retinoblastoma"
        },
        {
          "id": 4,
          "text": "Ewing’s sarcoma"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>High-dose methotrexate with leucovorin rescue (HDM-L) is a standard agent for adjuvant therapy of <strong>osteosarcoma</strong>.&nbsp;HDM is critical in the management of childhood acute lymphocytic leukemia (ALL). HDM-L also produces a high response rate in CNS lymphomas.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1153",
      "difficulty": "medium"
    },
    {
      "text": "A 53-year-old hypertensive patient has been on ACE inhibitors for the last 12 years. Which of the following effects would you expect to see in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Rightward shift in renal pressure natriuresis curve"
        },
        {
          "id": 2,
          "text": "Reduction in filtration fraction"
        },
        {
          "id": 3,
          "text": "Significant increase in heart rate"
        },
        {
          "id": 4,
          "text": "Decrease in compliance of large arteries"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>ACE inhibitors,</strong> when used for a long time in patients with hypertension, cause<strong>&nbsp;</strong>a<strong> reduction in filtration fraction.</strong></p>\n<p>Filtration fraction is the ratio of GFR to that of renal plasma flow. ACE inhibitors <strong>increase renal blood flow</strong> without altering GFR and thus result in reduction of filtration fraction.</p>\n<p>Option A:&nbsp;The graph plotted between urinary sodium excretion and mean blood pressure is known as the <strong>pressure natriuresis curve.</strong> For example, when dietary sodium intake is low, renin release is stimulated. <strong>Angiotensin II</strong> acts on the kidneys to shift the renal pressure &ndash; natriuresis curve to the <strong>right. </strong>This&nbsp;increases sodium and water retention.&nbsp;</p>\n<p>Conversely, when dietary Na+ is high or when ACE inhibitors are used, there is the <strong>withdrawal of angiotensin II</strong>. The renal pressure natriuresis curve shifts to the <strong>left.</strong></p>\n<p>The following image depicts a pressure natriuresis curve:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2612147181bf421c80443ad4c6b7cb6bx1280x1347.JPEG\" alt=\"Explanation Image\"><p>Options C and D: ACE inhibitors do not cause a significant increase in heart rate and can have a <strong>favorable change</strong> in the <strong>compliance of large arteries</strong> on long-term use.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4697",
      "difficulty": "medium"
    },
    {
      "text": "“Proof of concept” for a new drug is generally proven in which phase of a clinical trial?",
      "choices": [
        {
          "id": 1,
          "text": "Phase I"
        },
        {
          "id": 2,
          "text": "Phase II"
        },
        {
          "id": 3,
          "text": "Phase III"
        },
        {
          "id": 4,
          "text": "Phase IV"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>&ldquo;<strong>Proof of concept</strong>&rdquo; for a new drug is generally proven in&nbsp;<strong>phase II</strong> <strong>of a clinical trial</strong>.</p>\n<p>Phase II of clinical trials</p>\n<ul>\n<li>It involves a small group of patients (50-500).</li>\n<li>Most of the <strong>new drugs will be administered for the first time in patients</strong> with the target disease.</li>\n<li>The study is designed to obtain \"<strong>Proof of concept</strong>\"(Potential of the drug to treat the disease) and <strong>dose-ranging study</strong> (provides input for choosing the most appropriate dose for phase III studies).</li>\n</ul>\n<p>&nbsp;</p><hr><h3>Related Pearl: Phases of Clinical Trials</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Phase I</strong></p>\n<p>(First in human)</p>\n</td>\n<td>\n<p><strong>Phase II</strong></p>\n<p>(First in patient)</p>\n</td>\n<td>\n<p><strong>Phase III</strong></p>\n<p>(Multi-site trial)</p>\n</td>\n<td>\n<p><strong>Phase IV</strong></p>\n<p>(Post-marketing)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>10 – 100 </p>\n</td>\n<td>\n<p>50 - 500 </p>\n</td>\n<td>\n<p>500 - 3000</p>\n</td>\n<td>\n<p>Large or according to study</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Usually healthy volunteers</p>\n</td>\n<td>\n<p>Patients with the target disease</p>\n</td>\n<td>\n<p>Patients with the target disease</p>\n</td>\n<td>\n<p>Real-world patients</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Open-label study</p>\n</td>\n<td>\n<p>Randomized and controlled trial; may be blinded</p>\n</td>\n<td>\n<p>Randomized and controlled trial; may be blinded</p>\n</td>\n<td>\n<p>Usually the observational or open-label</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Human pharmacology </strong>and<strong> safety</strong>: To determine safety, tolerability and pharmacokinetic parameters</p>\n</td>\n<td>\n<p><strong>Therapeutic exploration </strong>and<strong> dose-ranging</strong>: To determine efficacy and dose-ranging</p>\n</td>\n<td>\n<p> </p>\n<p><strong>Therapeutic confirmation </strong>and <strong>comparison</strong>: Indications are finalized and guidelines for therapeutic use are formulated. Monitoring of adverse reactions is done. </p>\n</td>\n<td>\n<p><strong>Postmarketing surveillance</strong>: To monitor drug interactions, compliance and long-term or rare side effects</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Extends from months to 1 year</p>\n</td>\n<td>\n<p>1–2 years</p>\n</td>\n<td>\n<p>3–5 years</p>\n</td>\n<td>\n<p>Unending, after drug approval</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4358",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is not true regarding aspirin?",
      "choices": [
        {
          "id": 1,
          "text": "It is bound to albumin."
        },
        {
          "id": 2,
          "text": "It irreversibly inhibits COX."
        },
        {
          "id": 3,
          "text": "Acidification of urine helps in its excretion."
        },
        {
          "id": 4,
          "text": "It is an organic acid with pKa of 3.5."
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Acidification of urine does not help in the excretion of aspirin.</p>\n<p><strong>Aspirin</strong>&nbsp;<strong>and</strong>&nbsp;<strong>salicylates</strong>&nbsp;are&nbsp;<strong>acidic</strong>&nbsp;in nature.<strong>&nbsp;Alkalinization</strong>&nbsp;of the&nbsp;<strong>urine</strong>&nbsp;<strong>increases the rate of excretion</strong>&nbsp;of aspirin as the ionised form of aspirin increases which is not reabsorbed from the tubular fluid in the kidney.&nbsp;</p>\n<p>Option A- Around 80-90% of salicylates are bound to plasma proteins especially albumin.&nbsp;</p>\n<p>Option D- Aspirin (acetylsalicylic acid) has a pKa of 3.5.</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6783",
      "difficulty": "easy"
    },
    {
      "text": "In which of the following patients is transdermal selegiline approved for use?",
      "choices": [
        {
          "id": 1,
          "text": "30-year-old man with obsessive compulsive disorder"
        },
        {
          "id": 2,
          "text": "64-year-old man with Parkinson's disease"
        },
        {
          "id": 3,
          "text": "29-year-old woman with depression"
        },
        {
          "id": 4,
          "text": "33-year-old woman with generalized anxiety disorder"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Selegiline transdermal</strong> patch is <strong>approved</strong> for<strong> depression.&nbsp;</strong>The transdermal patch provides the high concentration required for antidepressant action.&nbsp;At higher doses, MAO-A is also inhibited and is highly effective in depression.&nbsp;</p>\n<p>Selegiline is a selective MAO-B inhibitor at low doses. It is used in Parkinson's disease at low doses, administered orally.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2642",
      "difficulty": "medium"
    },
    {
      "text": "A patient developed thyroid storm in the post-operative ward and was immediately started on IV propranolol and a loading dose of propylthiouracil. The antithyroid drug acts by inhibiting which of the following deiodinases?",
      "choices": [
        {
          "id": 1,
          "text": "D1 only"
        },
        {
          "id": 2,
          "text": "D2 only"
        },
        {
          "id": 3,
          "text": "D1 and D2"
        },
        {
          "id": 4,
          "text": "D3"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Propylthiouracil inhibits </strong>only&nbsp;<strong>type I deiodinase (D1).</strong></p>\n<p>Deiodinases are the enzymes that are involved in the peripheral conversion of T4 to either T3 or reverse T3. Type I deiodinase (D1) and type II deiodinase (D2) convert T4 to T3. Type III (D3) is involved in the conversion of T4 to reverse T3.&nbsp;</p>\n<p>Note:<strong> Amiodarone</strong> <strong>inhibits</strong> both <strong>types I and type II</strong> deiodinases.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/686777488e554c3a874bb81252c8993cx1280x1660.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9336",
      "difficulty": "hard"
    },
    {
      "text": "A 45-year-old lady, diagnosed with breast cancer, is started on a selective estrogen receptor modulator. Identify the drug.",
      "choices": [
        {
          "id": 1,
          "text": "Raloxifene"
        },
        {
          "id": 2,
          "text": "Mifepristone"
        },
        {
          "id": 3,
          "text": "Danazol"
        },
        {
          "id": 4,
          "text": "Anastrozole"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Raloxifene</strong> is a selective estrogen receptor modulator.&nbsp;</p>\n<p>It has <strong>agonist</strong> action on<strong> bone</strong> and <strong>antagonist</strong> action on<strong>&nbsp;</strong>the<strong> breast and uterus</strong>.</p>\n<p>It is used in the treatment and prevention of<strong> osteoporosis</strong> and in<strong> breast cancer prevention</strong> in high-risk <strong>postmenopausal women.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0753",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is true about ketorolac?",
      "choices": [
        {
          "id": 1,
          "text": "Has potent anti inflammatory activity"
        },
        {
          "id": 2,
          "text": "It's analgesic action is equal to morphine in post-operative pain"
        },
        {
          "id": 3,
          "text": "It is used as a pre anaesthetic medication"
        },
        {
          "id": 4,
          "text": "It interacts with opiod receptors"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Analgesic action of ketorolac is equal to morphine in post-operative pain</p>\n<p>Ketorolac, an NSAID is an aryl acetic acid derivative with the following properties</p>\n<ul>\n<li>It has <strong>mild anti-inflammatory</strong> action but is a <strong>potent analgesic</strong> (Option A). In<strong> postoperative pain reduction, </strong>the efficacy of <strong>ketorolac is comparable to morphine</strong>. Many studies have concluded that the analgesic action of ketorolac is equivalent to morphine.&nbsp;</li>\n<li>It does not interact with the opioid receptors and is therefore free of the opioid side effects (<strong>Option D</strong>)</li>\n<li>It is mainly used in postoperative pain relief (<strong>Option C</strong>)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6811",
      "difficulty": "medium"
    },
    {
      "text": "Which among the following antihistaminic drugs has additional platelet-activating factor antagonistic property?",
      "choices": [
        {
          "id": 1,
          "text": "Fexofenadine"
        },
        {
          "id": 2,
          "text": "Cetirizine"
        },
        {
          "id": 3,
          "text": "Ebastine"
        },
        {
          "id": 4,
          "text": "Rupatadine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Rupatadine</strong> is an antihistaminic drug that has additional<strong> platelet activating</strong> <strong>factor</strong> <strong>antagonistic property&nbsp;</strong>and is indicated in allergic rhinitis.</p>\n<p>Platelet-activating factor (PAF)&nbsp;is&nbsp;involved in the pathophysiology of allergic rhinitis, asthma, and anaphylaxis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7416",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following does not belong to class 1A antiarrhythmics?",
      "choices": [
        {
          "id": 1,
          "text": "Quinidine"
        },
        {
          "id": 2,
          "text": "Propafenone"
        },
        {
          "id": 3,
          "text": "Procainamide"
        },
        {
          "id": 4,
          "text": "Disopyramide"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<ul>\n<li><strong>Propafenone belongs to class IC antiarrhythmics.</strong></li>\n</ul>\n<ul>\n<li>Class 1A antiarrhythmics are quinidine, procainamide, disopyramide.</li>\n</ul><hr><h3>Related Pearl: Anti-arrhythmic drugs</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7d6c4d5ed4a54f70b2030d71f3d06969x1280x1697.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Class of antiarrhythmic drugs&nbsp;</strong></span></p>\n</td>\n<td>\n<p><span>&nbsp;</span></p>\n<p><span><strong>Mechanism of action</strong></span></p>\n</td>\n<td>\n<p><span><strong>Effect on action potential duration</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class I</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IA</strong></span></p>\n<p><span>Procainamide</span></p>\n<p><span>Quinidine</span></p>\n<p><span>Disopyramide</span></p>\n</td>\n<td>\n<p><span>&nbsp;</span></p>\n<p><span>Na+ channel blockers with significant K<sup>+</sup> channel blocking property</span></p>\n<p><span>&nbsp;</span></p>\n</td>\n<td>\n<p><span>Prolonged</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IB</strong></span></p>\n<p><span>Lidocaine</span></p>\n<p><span>Mexiletine</span></p>\n</td>\n<td><span>Na+ channel blockers with K<sup>+</sup> channel opening property&nbsp;</span></td>\n<td>\n<p><span>Shortened or no effect</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IC</strong></span></p>\n<p><span>Flecainide</span></p>\n<p><span>Propafenone</span></p>\n<p><span>Moricizine</span></p>\n</td>\n<td><span>Na+ channel blockers with negligible K<sup>+</sup> channel blocking property&nbsp;</span></td>\n<td>\n<p><span>Variable or no effect</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class II</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Propranolol</span></p>\n<p><span>Esmolol</span></p>\n</td>\n<td><span>&beta;- blockers</span></td>\n<td><span>-&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class III</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Amiodarone, dronedarone</span></p>\n<p><span>Dofetilide</span></p>\n<p><span>Sotalol</span></p>\n<p><span>Ibutilide</span></p>\n<p><span>Vernakalant</span></p>\n</td>\n<td><span>K<sup>+</sup> channel blockers&nbsp;</span></td>\n<td><span>Prolonged&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IV</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Verapamil</span></p>\n<p><span>Diltiazem</span></p>\n</td>\n<td><span>Ca<sup>2+</sup> channel blockers</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Miscellaneous</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Adenosine</span></p>\n</td>\n<td><span>Activates adenosine receptors</span></td>\n<td><span>Shortened</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Digoxin</span></p>\n</td>\n<td><span>Na<sup>+</sup>-K<sup>+</sup> ATPase inhibitor</span></td>\n<td><span>Increases AV node refractoriness</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Magnesium</span></p>\n</td>\n<td><span>Unknown</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1908",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not a prodrug?",
      "choices": [
        {
          "id": 1,
          "text": "Clopidogrel"
        },
        {
          "id": 2,
          "text": "Prasugrel"
        },
        {
          "id": 3,
          "text": "Ticagrelor"
        },
        {
          "id": 4,
          "text": "Ticlopidine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Ticagrelor</strong>&nbsp;is <strong>not a prodrug</strong> and does not require metabolic activation to exert its antiplatelet action.</p>\n<p>It is an orally active, <strong>reversible antagonist of P2Y12</strong> subtype of ADP receptors. Since the drug does not require hepatic activation, it can be <strong>used in patients with CYP2C19 mutations.</strong>&nbsp;Ticagrelor is metabolized into another active metabolite&nbsp;by CYP3A4 and is finally excreted in the urine.</p>\n<p>Clopidogrel, prasugrel, and ticlopidine are <strong>irreversible</strong> antagonists of P2Y12 and are <strong>prodrugs</strong> requiring metabolic activation.</p><hr><h3>Related Pearl: Classification of anti-platelet drugs</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Class</strong></span></td>\n<td><span><strong>Drugs</strong></span></td>\n</tr>\n<tr>\n<td><span>Cyclooxygenase- I inhibitors</span></td>\n<td><span>Aspirin</span></td>\n</tr>\n<tr>\n<td><span>Irreversible P2Y<sub>12&nbsp;</sub>inhibitors</span></td>\n<td>\n<p><span>Ticlopidine, Clopidogrel, Prasugrel</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Reversible P2Y<sub>12&nbsp;</sub>inhibitors</span></td>\n<td><span>Ticagrelor, Cangrelor</span></td>\n</tr>\n<tr>\n<td><span>GpIIb/IIIa inhibitors</span></td>\n<td><span>Abciximab, Eptifibatide, Tirofiban</span></td>\n</tr>\n<tr>\n<td><span>Thrombin (PAR-1) receptor antagonist</span></td>\n<td><span>Vorapaxar&nbsp;</span></td>\n</tr>\n<tr>\n<td><span>Phosphodiesterase inhibitors</span></td>\n<td>\n<p class=\"p1\"><span>Dipyridamole</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA8085",
      "difficulty": "medium"
    },
    {
      "text": "A middle-aged man came to the casualty with complaints of abdominal pain. On examination, it is noted that the pain radiates from the loin to the groin of the patient. The resident wants to administer a drug to the patient for symptomatic relief. Which drug is not effective in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Paracetamol"
        },
        {
          "id": 2,
          "text": "Aspirin"
        },
        {
          "id": 3,
          "text": "Morphine"
        },
        {
          "id": 4,
          "text": "Nitrates"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Abdominal pain radiating from loin to groin is suggestive of <strong>renal</strong> <strong>colic</strong>. <strong>Nitrates</strong> are <strong>not effective</strong> in renal colic.&nbsp;</p>\n<p>In renal colic,<strong> NSAIDs</strong>,&nbsp;and <strong>morphine</strong> are used for acute pain relief. Due to the short time of action of nitrates, their clinical efficacy as relaxants in genitourinary system is quite low.</p>\n<p><strong>Therapeutic Uses of nitrates</strong> are:</p>\n<ul>\n<li>Angina pectoris</li>\n<li>Acute coronary syndrome</li>\n<li>Myocardial infarction</li>\n<li>CHF</li>\n<li>Biliary colic</li>\n<li>Esophageal spasm</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1437",
      "difficulty": "medium"
    },
    {
      "text": "A pregnant woman came for routine antenatal screening. During prenatal testing, the fetus was suspected to have congenital adrenal hyperplasia. What is the drug of choice for treating the fetus in-utero?",
      "choices": [
        {
          "id": 1,
          "text": "Dexamethasone"
        },
        {
          "id": 2,
          "text": "Betamethasone"
        },
        {
          "id": 3,
          "text": "Hydrocortisone"
        },
        {
          "id": 4,
          "text": "Prednisolone"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>drug of choice</strong> for treating the <strong>fetus</strong> in-utero when suspected of having<strong> congenital adrenal hyperplasia</strong> is <strong>dexamethasone.</strong></p>\n<p>Dexamethasone readily <strong>crosses the placenta </strong>and suppresses the secretion of steroids and androgens by fetal adrenal glands. If started by 6 weeks of gestation, it reduces the virilization of external genitalia in affected females.</p>\n<p><strong>Chorionic villus biopsy</strong> is then performed to determine the sex and the genotype of the fetus and therapy is only continued if the fetus is an <strong>affected female.</strong></p>\n<p>This is not widely accepted currently due to insufficient data on long-term risks especially in unaffected females and males who derive no benefit from the treatment.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9950",
      "difficulty": "medium"
    },
    {
      "text": "Most rapid acting PDE-5 inhibitor is____",
      "choices": [
        {
          "id": 1,
          "text": "Sildenafil"
        },
        {
          "id": 2,
          "text": "Tadalafil"
        },
        {
          "id": 3,
          "text": "Vardenafil"
        },
        {
          "id": 4,
          "text": "Avanafil"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<ul>\n<li><strong>Avanafil is having rapid onset of action of around 15-30 minutes. </strong></li>\n<li>Clinical correlate</li>\n<li>Timing of administration before sexual activity of PDE-5 inhibitors depends upon their onset of action\n<ul>\n<li>Avanafil: 15-30 minutes</li>\n<li>Vardenafil: 1 hour</li>\n<li>Sildenafil: 1 hour</li>\n<li>Tadalafil: can be given at any time because of long duration of action (low dose)</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0793",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is a bradykinin receptor antagonist?",
      "choices": [
        {
          "id": 1,
          "text": "Rimonabant"
        },
        {
          "id": 2,
          "text": "Icatibant"
        },
        {
          "id": 3,
          "text": "Moexipril"
        },
        {
          "id": 4,
          "text": "Eprosartan"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Icatibant is a selective bradykinin B2 receptor antagonist</strong>. It is approved for the use of hereditary angioedema. Icatibant reduces the hypotensive action of captopril indicating the role of inhibition of bradykinin breakdown in hypotensive action of captopril.</p>\n<p>Rimonabant is a <strong>cannabinoid receptor antagonist</strong> that was used in obesity but withdrwan due to serious psychiatric adverse effects <strong>(Option</strong> <strong>A</strong>).</p>\n<p>Moexipril is an <strong>angiotensin converting enzyme inhibitor</strong> (<strong>Option C</strong>).</p>\n<p>Eprosartan is an <strong>antiotensin receptor blocker</strong> (<strong>Option D</strong>).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4707",
      "difficulty": "medium"
    },
    {
      "text": "A 43-year-old man who is a  known case of hypertension was started on a beta-blocker. Which of the following adverse effects is least likely to be seen?",
      "choices": [
        {
          "id": 1,
          "text": "Bradycardia"
        },
        {
          "id": 2,
          "text": "Sedation"
        },
        {
          "id": 3,
          "text": "Cold extremities"
        },
        {
          "id": 4,
          "text": "Bronchoconstriction"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Sedation&nbsp;</strong>is least likely to be seen with beta-blockers. Beta-blockers usually cause sleep disturbances like insomnia and nightmares.</p>\n<p>The main adverse effects of beta-blockers are:</p>\n<ul>\n<li>Cardiovascular side effects - exacerbation of heart failure, bradyarrhythmias, cold extremities, worsening of peripheral vascular disease, Raynaud phenomenon.</li>\n<li>Respiratory side effects like life-threatening bronchoconstriction can occur.</li>\n<li>Neurological side effects include fatigue. insomnia, nightmares and depression.&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2105",
      "difficulty": "medium"
    },
    {
      "text": "Sargramostim is a recombinantly engineered analogue of which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "G-CSF"
        },
        {
          "id": 2,
          "text": "GM-CSF"
        },
        {
          "id": 3,
          "text": "Erythropoietin"
        },
        {
          "id": 4,
          "text": "IL-11"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p class=\"p1\"><strong>Sargramostim&nbsp;</strong>is a <strong>recombinant human GM-CSF </strong>(Granulocyte-macrophage colony-stimulating factor).</p>\n<p class=\"p1\">Indications for use:</p>\n<ul>\n<li>Autologous <strong>bone marrow transplant</strong>&nbsp;<strong>-</strong> reduces the duration of neutropenia</li>\n<li>Cancer <strong>chemotherapy -</strong>&nbsp;reduces the duration of neutropenia</li>\n<li>Peripheral blood <strong>stem cell collection -</strong>&nbsp;to mobilize CD34 positive progenitor cells</li>\n</ul>\n<p class=\"p1\">It is administered subcutaneously or by slow intravenous infusion.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA8064",
      "difficulty": "easy"
    },
    {
      "text": "A 43-year-old lady with papillary thyroid cancer is being treated with radioactive iodine 131. What is the half-life of this isotope?",
      "choices": [
        {
          "id": 1,
          "text": "8 hours"
        },
        {
          "id": 2,
          "text": "8 days"
        },
        {
          "id": 3,
          "text": "8 weeks"
        },
        {
          "id": 4,
          "text": "8 years"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The half-life of radioactive<strong> I<sup> 131 </sup></strong>is <strong>8 days</strong></p>\n<p><strong>I<sup>131</sup></strong> emits both <strong>beta and gamma rays.&nbsp;</strong>It is used both for <strong>diagnostic and therapeutic</strong> purposes for thyroid disorders.&nbsp;</p>\n<p><strong>I<sup>127</sup></strong> is the <strong>stable isotope</strong> of iodine.&nbsp;</p>\n<p><strong>I<sup>123 </sup></strong>is the radioactive isotope of iodine that <strong>emits only gamma rays.</strong>&nbsp;The action is short-lived with a half-life&nbsp;of around 13 hours.<strong>&nbsp;</strong>It is indicated for <strong>diagnostic</strong> indications only.&nbsp;</p><hr><h3>Related Pearl: Half life of radio isotopes</h3><table>\n<tbody>\n<tr>\n<td><strong>Radioisotope</strong></td>\n<td><strong>Half-life</strong></td>\n</tr>\n<tr>\n<td>Cobalt 60</td>\n<td>5.2 years</td>\n</tr>\n<tr>\n<td>Iridium 192</td>\n<td>74 days</td>\n</tr>\n<tr>\n<td>Iodine 131</td>\n<td>8 days</td>\n</tr>\n<tr>\n<td>Iodine 125</td>\n<td>60 days</td>\n</tr>\n<tr>\n<td>Iodine 123</td>\n<td>13 hours</td>\n</tr>\n<tr>\n<td>Iodine 132</td>\n<td>3 hours&nbsp;</td>\n</tr>\n<tr>\n<td>Cesium 137</td>\n<td>30 years</td>\n</tr>\n<tr>\n<td>Technetium 99m</td>\n<td>6 Hours</td>\n</tr>\n<tr>\n<td>18 FDG</td>\n<td>110 minutes</td>\n</tr>\n<tr>\n<td>Radon 222</td>\n<td>3.8 days</td>\n</tr>\n<tr>\n<td>Radium 226</td>\n<td>1600 years</td>\n</tr>\n<tr>\n<td>Strontium-89</td>\n<td>50.5 days</td>\n</tr>\n<tr>\n<td>Strontium- 90</td>\n<td>28 years</td>\n</tr>\n<tr>\n<td>Phosphorus 32</td>\n<td>14 days</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9345",
      "difficulty": "medium"
    },
    {
      "text": "Vasodilator used topically for the treatment of alopecia:",
      "choices": [
        {
          "id": 1,
          "text": "Hydralazine"
        },
        {
          "id": 2,
          "text": "Diazoxide"
        },
        {
          "id": 3,
          "text": "Minoxidil"
        },
        {
          "id": 4,
          "text": "Nitrates"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Topical minoxidil is used for the treatment of androgeneticic alopecia in both male and female patients.</strong></p>\n<p>Mechanism of action:&nbsp;</p>\n<p>Exact mechanism is not known yet.&nbsp;</p>\n<ul>\n<li>May act at the level of hair follicle involving direct stimulation of hair follicle cells&nbsp;</li>\n<li>May stimulate cutaneous blood flow&nbsp;</li>\n</ul>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2172",
      "difficulty": "easy"
    },
    {
      "text": "A 65-year-old woman with chronic kidney disease was given a diuretic intravenously. Following administration of the drug, she developed tinnitus and diminished hearing. Which of the following drugs was most likely given?",
      "choices": [
        {
          "id": 1,
          "text": "Thiazide"
        },
        {
          "id": 2,
          "text": "Spirinolactone"
        },
        {
          "id": 3,
          "text": "Ethacrynic acid"
        },
        {
          "id": 4,
          "text": "Triamterene"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Ethacrynic acid </strong>is the diuretic that was most likely given as it is commonly associated with<strong> ototoxicity</strong>.</p>\n<p>Ototoxicity occurs with <strong>rapid intravenous infusion</strong> and the hearing impairment and deafness are usually <strong>reversible.</strong></p>\n<p>Ethacrynic acid should be used only in patients who are not able to tolerate other loop diuretics.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5420",
      "difficulty": "medium"
    },
    {
      "text": "Maternal and fetal outcomes are worse with_______",
      "choices": [
        {
          "id": 1,
          "text": "Beta 2 agonists"
        },
        {
          "id": 2,
          "text": "Calcium channel blockers"
        },
        {
          "id": 3,
          "text": "Atosiban"
        },
        {
          "id": 4,
          "text": "Similar outcomes with A, B, C"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<ul>\n<li>Beta 2 agonists can lead to fetal hypoxia due to decreased placental perfusion. Maternal effects like tachycardia, hypotension, and pulmonary edema can be seen. The first approved exclusive beta 2 agonist tocolytic ritodrine was voluntarily withdrawn from the market.</li>\n<li><strong>A meta-analysis has shown both calcium channel blockers and atosiban to have better maternal and fetal outcomes among tocolytics.</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1290",
      "difficulty": "hard"
    },
    {
      "text": "What is the most potent statin?",
      "choices": [
        {
          "id": 1,
          "text": "Simvastatin"
        },
        {
          "id": 2,
          "text": "Pitavastatin"
        },
        {
          "id": 3,
          "text": "Atorvastatin"
        },
        {
          "id": 4,
          "text": "Rosuvastatin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<ul>\n<li>Among the statins, PITAVASTATIN is the latest and most potent statin. Use of pitavastatin along with gemfibrozil should be avoided as the latter decreases its clearance.</li>\n</ul>\n<ul>\n<li>ROSUVASTATIN has the longest t<sub>1/2</sub> among the statins.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2021",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is a selective imidazoline receptor agonist?",
      "choices": [
        {
          "id": 1,
          "text": "Clonidine"
        },
        {
          "id": 2,
          "text": "Methyldopa"
        },
        {
          "id": 3,
          "text": "Moxonidine"
        },
        {
          "id": 4,
          "text": "Brimonidine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Moxonidine </strong>is a selective<strong> imidazoline </strong>(I<sub>1</sub>) receptor<strong> agonist.</strong></p>\n<p>It&nbsp;is indicated as a second line agent in the long-term management of <strong>hypertension</strong>. It also has weak alpha 2 agonist action.</p>\n<p><strong>Rilmenidine</strong> is another selective imidazoline receptor agonist.</p>\n<p>Option&nbsp;A: <strong>Clonidine</strong> is an alpha 2 receptor partial agonist and has additional imidazoline (I<sub>1</sub>) receptor agonist action. But the <strong>main</strong> mode of <strong>action</strong> is through <strong>alpha 2 agonism</strong>.</p>\n<p>Option B: Methyldopa does not have any action on imidazoline receptors</p>\n<p>Option D: Brimonidine is a congener of clonidine.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2123",
      "difficulty": "medium"
    },
    {
      "text": "A 52-year-old man with alcoholic cirrhosis develops ascites. What is the drug of choice for management?",
      "choices": [
        {
          "id": 1,
          "text": "Chlorothiazide"
        },
        {
          "id": 2,
          "text": "Acetazolamide"
        },
        {
          "id": 3,
          "text": "Spironolactone"
        },
        {
          "id": 4,
          "text": "Mannitol"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The diuretic of choice in a patient with<strong> cirrhotic ascites&nbsp;</strong>is <strong>spironolactone.</strong></p>\n<p><strong>Spironolactone</strong> is a <strong>competitive inhibitor</strong> of the <strong>mineralocorticoid receptor</strong> in the <strong>late distal tubule</strong> and<strong> collecting duct</strong> of the kidneys. It causes a decrease in sodium reabsorption and potassium excretion in the distal tubule. As a result, spironolactone <strong>promotes sodium diuresis</strong> but <strong>maintains body potassium levels</strong>.</p>\n<p>Spironolactone is particularly helpful in edematous states caused or exacerbated by hyperaldosteronism such as in cirrhotic ascites.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5462",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is a prodrug?",
      "choices": [
        {
          "id": 1,
          "text": "Prednisolone"
        },
        {
          "id": 2,
          "text": "Methylprednisolone"
        },
        {
          "id": 3,
          "text": "Hydrocortisone"
        },
        {
          "id": 4,
          "text": "Prednisone"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Prednisone</strong> is a <strong>prodrug</strong>.</p>\n<p>It is a <strong>synthetic</strong> <strong>glucocorticoid</strong> that is biologically inert until converted via <strong>hepatic metabolism</strong>&nbsp;(11-beta HSD1) to the active component, <strong>prednisolone.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9916",
      "difficulty": "medium"
    },
    {
      "text": "A 50-year-old man who is on treatment for small cell carcinoma of the lung presents with acute onset confusion, nausea, and vomiting. He appears to be euvolemic. Laboratory investigations reveal serum sodium levels to be 120 mEq/l and urine osmolality is 300 mOsm/kg . Which of the following is not used as a treatment option in his condition?",
      "choices": [
        {
          "id": 1,
          "text": "Demeclocycline"
        },
        {
          "id": 2,
          "text": "Desmopressin"
        },
        {
          "id": 3,
          "text": "Restriction of free water intake"
        },
        {
          "id": 4,
          "text": "3% NaCl"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of syndrome of inappropriate ADH secretion (<strong>SIADH</strong>) which can occur as a paraneoplastic syndrome of small cancer of the lung. Desmopressin is not used in the treatment of SIADH.</p>\n<p>Since excess vasopressin is the cause for SIADH, giving a vasopressin analog like <strong>desmopressin</strong> would only <strong>worsen the condition</strong>.&nbsp;</p>\n<p><strong>Management</strong> of SIADH:</p>\n<ul>\n<li><strong>Fluid restriction</strong>&nbsp;</li>\n<li><strong>Hypertonic saline</strong>( 3%) + <strong>loop diuretics</strong> is the treatment of choice in <strong>severe symptomatic hyponatremia</strong>.</li>\n<li>Tolvaptan and conivaptan (<strong>vasopressin receptor antagonists</strong>) are preferred for long-term use.</li>\n<li>Demeclocycline (a tetracycline drug) is used as an alternative.</li>\n</ul><hr><h3>Related Pearl: Causes of SIADH</h3><p><strong>Neoplasms</strong></p>\n<p><strong>Carcinomas</strong></p>\n<ul>\n<li>Lung</li>\n<li>Duodenum</li>\n<li>Pancreas</li>\n<li>Ovary</li>\n<li>Bladder, ureter</li>\n</ul>\n<p><strong>Other neoplasms</strong></p>\n<ul>\n<li>Thymoma</li>\n<li>Mesothelioma</li>\n<li>Bronchial adenoma</li>\n<li>Carcinoid</li>\n<li>Gangliocytoma</li>\n<li>Ewing&rsquo;s sarcoma</li>\n</ul>\n<p><strong>Head trauma</strong> (closed and penetrating)</p>\n<p><strong>Infections</strong></p>\n<ul>\n<li>Pneumonia</li>\n<li>Abscess</li>\n<li>Cavitation (aspergillosis)</li>\n<li>Tuberculosis</li>\n<li>Meningitis, Encephalitis</li>\n<li>AIDS</li>\n</ul>\n<p><strong>Vascular</strong></p>\n<ul>\n<li>Cerebrovascular occlusions, haemorrhage</li>\n<li>Cavernous sinus thrombosis</li>\n</ul>\n<p><strong>Neurologic</strong></p>\n<ul>\n<li>Guillain-Barre syndrome</li>\n<li>Multiple sclerosis</li>\n<li>Delirium tremens</li>\n<li>Amyotrophic lateral sclerosis</li>\n<li>Hydrocephalus</li>\n<li>Psychosis</li>\n<li>Peripheral neuropathy</li>\n</ul>\n<p><strong>Congenital malformations</strong></p>\n<p><strong>Metabolic</strong></p>\n<ul>\n<li>Acute intermittent porphyria</li>\n</ul>\n<p><strong>Respiratory</strong></p>\n<ul>\n<li>Asthma</li>\n<li>Pneumothorax</li>\n<li>Positive-pressure respiration</li>\n</ul>\n<p><strong>Drugs</strong></p>\n<ul>\n<li>Vasopressin or desmopressin</li>\n<li>Serotonin reuptake inhibitors</li>\n<li>Oxytocin (high dose)</li>\n<li>Vincristine</li>\n<li>Carbamazepine</li>\n<li>Nicotine</li>\n<li>Phenothiazines</li>\n<li>Cyclophosphamide</li>\n<li>Tricyclic antidepressants</li>\n<li>Monoamine oxidase inhibitors</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5562",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is a correct statement regarding antiarrhythmics?",
      "choices": [
        {
          "id": 1,
          "text": "Sotalol has additional class II action"
        },
        {
          "id": 2,
          "text": "Esmolol has additional class IV action"
        },
        {
          "id": 3,
          "text": "Propranolol has additional class I action"
        },
        {
          "id": 4,
          "text": "Both A and C"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Sotalol</strong> has<strong> both class II</strong> (beta-blocker) <strong>and class III action</strong> (K+ channel blockade). Though it is a nonselective beta-blocker, as an antiarrhythmic, it is classified under class III.&nbsp;</p>\n<p>Propranolol is a non-selective beta-blocker with additional membrane-stabilizing action especially at higher doses: Na+ channel blockade/ class I action.</p>\n<p>Esmolol is a beta 1 selective blocker that does not have any additional class effect.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1991",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following adverse effects is least likely in a patient who is on chronic amiodarone therapy?",
      "choices": [
        {
          "id": 1,
          "text": "Dry cough"
        },
        {
          "id": 2,
          "text": "Corneal microdeposits"
        },
        {
          "id": 3,
          "text": "Hepatic dysfunction"
        },
        {
          "id": 4,
          "text": "Nephrotoxicity"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Nephrotoxicity is not an adverse effect of&nbsp;chronic amiodarone therapy.&nbsp;<strong>Pulmonary fibrosis</strong>&nbsp;associated with <strong>dry cough</strong> is the most serious side effect of<strong> chronic amiodarone therapy</strong>. It can rapidly progress and become fatal.</p>\n<p>The side effects of amiodarone include:</p>\n<ul>\n<li>Pulmonary fibrosis</li>\n<li>Hypotension, depressed ventricular function</li>\n<li>Torsades de pointes</li>\n<li><strong>Corneal microdeposits</strong></li>\n<li><strong>Hepatotoxicity</strong></li>\n<li>Neuropathies</li>\n<li>Photosensitivity</li>\n<li>Thyroid dysfunction</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1999",
      "difficulty": "easy"
    },
    {
      "text": "All of the following statements about octreotide are true except_______",
      "choices": [
        {
          "id": 1,
          "text": "It is effective orally"
        },
        {
          "id": 2,
          "text": "It is used in diagnostic imaging of Neuroendocrine tumors"
        },
        {
          "id": 3,
          "text": "It can be used for the management of secretory diarrhoea"
        },
        {
          "id": 4,
          "text": "It can be used in portal hypertension"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Octreotide is a long acting somatostatin analog. It is a peptide and<strong> ineffective orally</strong> but can be given either IM/SC/IV.</p>\n<p>It can be used in these conditions</p>\n<ul>\n<li>Decrease secretory diarrhea associated with neuroendocrine tumors like carcinoid and VIPoma <strong>(option c)</strong></li>\n<li>Decrease diarrhea associated with short bowel syndrome, AIDS</li>\n<li>Pituitary tumors causing acromegaly <strong>(option b)</strong></li>\n<li>Islet cell tumors: to reduce hormonal secretion</li>\n<li>Acute bleeding in esophageal varices seen in portal hypertension <strong>(option d)</strong></li>\n<li>GI or pancreatic fistula</li>\n<li>Thyrotrope adenomas</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9121",
      "difficulty": "easy"
    },
    {
      "text": "Maximum hepatic enzyme inhibition is seen with ______",
      "choices": [
        {
          "id": 1,
          "text": "Ranitidine"
        },
        {
          "id": 2,
          "text": "Cimetidine"
        },
        {
          "id": 3,
          "text": "Famotidine"
        },
        {
          "id": 4,
          "text": "Nizatidine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Cimetidine causes maximum hepatic enzyme inhibition among the given options.</strong></p>\n<p>Cimetidine inhibits CYP enzymes like CYP1A2, CYP2C9, and CYP2D6. It can interfere with the metabolism of drugs that are substrates of the above enzymes.</p>\n<p>Ranitidine also interacts with CYP enzymes but the affinity is only 10% to that of cimetidine (Option A).</p>\n<p>Famotidine and nizatidine are considered safer with respect to enzyme inhibition (Options C and D).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6529",
      "difficulty": "easy"
    },
    {
      "text": "Systemic steroids can cause all of the following except_______",
      "choices": [
        {
          "id": 1,
          "text": "Hypertension"
        },
        {
          "id": 2,
          "text": "Glaucoma"
        },
        {
          "id": 3,
          "text": "Cataract"
        },
        {
          "id": 4,
          "text": "Osteoporosis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<ul>\n<li><strong>Glaucoma is a side effect of prolonged topical therapy.</strong></li>\n<li>Hypertension, cataract, and osteoporosis are known side effects of systemic glucocorticoid therapy <strong>(options a, c and d).</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9928",
      "difficulty": "medium"
    },
    {
      "text": "Topical mitomycin C is used in which of the following patients?",
      "choices": [
        {
          "id": 1,
          "text": "A patient with Sturge-Weber syndrome"
        },
        {
          "id": 2,
          "text": "A patient with laryngotracheal stenosis"
        },
        {
          "id": 3,
          "text": "A patient undergoing endoscopic treatment of angiofibroma"
        },
        {
          "id": 4,
          "text": "A patient with hand-foot syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Topical mitomycin C is used in <strong>laryngotracheal stenosis</strong>.</p>\n<p>Mitomycin C is an antitumor antibiotic that inhibits cell division, protein synthesis and fibroblast proliferation. Topical mitomycin C has been shown to cause symptomatic improvement when applied to patients with laryngotracheal stenosis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1161",
      "difficulty": "easy"
    },
    {
      "text": "A 35-year-old lady, P2L2, has been taking depot medroxy progesterone acetate as a contraceptive. Which of the following best describes the formulation?",
      "choices": [
        {
          "id": 1,
          "text": "Long acting progesterone preparation"
        },
        {
          "id": 2,
          "text": "Long acting estrogen preparation"
        },
        {
          "id": 3,
          "text": "Long acting anti-progestin preparation"
        },
        {
          "id": 4,
          "text": "Short acting anti-progestin preparation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Depot medroxyprogesterone acetate (DMPA)</strong> is a long-acting progestin-only injection formulation.</p>\n<p>DMPA is administered every<strong> 3 months intramuscularly</strong> as a contraceptive.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0733",
      "difficulty": "easy"
    },
    {
      "text": "Osteomalacia in phenytoin is due to:",
      "choices": [
        {
          "id": 1,
          "text": "Altered metabolism of vitamin D"
        },
        {
          "id": 2,
          "text": "Altered metabolism of vitamin K"
        },
        {
          "id": 3,
          "text": "Both a and b"
        },
        {
          "id": 4,
          "text": "Direct action on parathyroid glands"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<ul>\n<li><strong>Osteomalacia due to phenytoin use is attributed to both alteration in vitamin D and vitamin K metabolism.</strong></li>\n</ul>\n<ul>\n<li>Alteration in vitamin D metabolism and the attendant inhibition in intestinal reabsorption of Ca<sup>2+</sup> contributes to hypocalcemia and osteomalacia.</li>\n</ul>\n<ul>\n<li>The increase in vitamin K metabolism reduces the concentration of vitamin K-dependent proteins that are important for normal Ca<sup>2+</sup> metabolism in bones. This is the reason why the osteomalacia due to phenytoin is not always ameliorated by the administration of vitamin D.</li>\n<li>Gamma carboxylation of osteocalcin and other important activities in bone requires vitamin K.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2208",
      "difficulty": "medium"
    },
    {
      "text": "Ampicillin use in EB virus infection increases the risk of _______",
      "choices": [
        {
          "id": 1,
          "text": "Hepatotoxicity"
        },
        {
          "id": 2,
          "text": "Skin rash"
        },
        {
          "id": 3,
          "text": "Blindness"
        },
        {
          "id": 4,
          "text": "Convulsions"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<ul>\n<li><strong>Ampicillin produces a very high incidence of rashes especially in patients with AIDS and EB virus infections or lymphatic leukemia. </strong></li>\n<li>Concurrent administration of allopurinol also increases the incidence of rashes. Sometimes the rashes may be toxic in nature.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA8581",
      "difficulty": "medium"
    }
  ]
}